Lung Cancer Screening, Diagnosis, and Interventions

Lung cancer remains the leading cause of cancer-related mortality worldwide, with early detection playing a critical role in improving survival rates. This session discusses the implementation and outcomes of low-dose computed tomography (LDCT) screening programs for high-risk populations. Emphasis is placed on advancements in imaging techniques, liquid biopsy, and biomarker-driven diagnostics. Treatment strategies, including minimally invasive surgical interventions, radiation therapy, and targeted therapies, are reviewed. The role of interventional pulmonology in diagnostic procedures such as EBUS and navigational bronchoscopy is explored. Discussions also cover patient selection, risk stratification, and shared decision-making in screening programs. This session provides a comprehensive overview of modern approaches to lung cancer detection and personalized intervention planning.

    Related Conference of Lung Cancer Screening, Diagnosis, and Interventions

    February 25-26, 2027

    3rd World Congress on Pathology and Laboratory Medicine

    Paris, France
    April 23-24, 2027

    15th Annual Congress on Pulmonary and Critical Care

    Paris, France

    Lung Cancer Screening, Diagnosis, and Interventions Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in